cobimetinib,vemurafenib
roche,exelixis
['tapur']
dr. richard schilsky talking about the tapur study in the #patient #advocate lounge. #asco22 
Stage IV colon cancer survivor, cancer patient/research advocate. Retired government senior executive. SWOG, NCI CIRB, OPTIMISTICC. COI:Bayer Patient Engagement